What's new

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised
Read More

Tags:

Previous Article

Veterinary medicines European public assessment report (EPAR): Tolfenamic acid V...

Next Article

P/87/2010

Related Posts

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

EMEA-002755-PIP01-19-M02

EMEA-002755-PIP01-19-M02

Feb 17, 2025  0